Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
Disrupting insulin and IGF receptor function in cancer
Jingran Cao,
Douglas Yee
Medicine - Hematology, Oncology, Transplant
Research output
:
Contribution to journal
›
Review article
›
peer-review
29
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Disrupting insulin and IGF receptor function in cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Somatomedin Receptors
87%
Insulin Receptor
74%
Somatomedins
70%
Neoplasms
21%
IGF Type 1 Receptor
11%
Phase III Clinical Trials
11%
Standard of Care
9%
Protein-Tyrosine Kinases
8%
Cell Survival
7%
Monoclonal Antibodies
6%
Direction compound
6%
Insulin
6%
Cell Proliferation
6%
Breast Neoplasms
6%
Therapeutics
1%
Physics & Astronomy
insulin
94%
disrupting
93%
cancer
61%
tyrosine
9%
antibodies
7%
inhibitors
7%
breast
6%
Engineering & Materials Science
Intercellular Signaling Peptides and Proteins
100%
Insulin
88%
Monoclonal antibodies
10%
Cell proliferation
9%
Chemical Compounds
Insulin Derivative
67%
Insulin-Like Growth Factor I
14%
Tyrosine Kinase Inhibitor
13%